Plantagen BS

Advertências

Hipersensibilidade a algum dos componentes

Forma de Apresentação

Frasco com 60 cápsulas de 610 mg

Bibliografia

1.- Siddiqui MZ. Boswellia serrata, a potential antiinflammatory agent: an overview. Indian J Pharm Sci. 2011 May; 73(3):255-61

2.-N. Kimmatkar, V. Thawani , L. Hingorani , and R. Khiyani. Efficacy and tolerability of Boswellia serrata extract in treatment of osteoarthritis of knee – A randomized double blind placebo controlled trial. Phytomedicine 10: 3–7 (2003)

3.- Gupta I, Gupta V, Parihar A, Gupta S, Lüdtke R, Safayhi H, Ammon HP Pharmakologie für Naturwissenschaftler, Pharmazeutisches Institut der Universität Tübingen, Auf der Morgenstelle 8, D-72076 Tübingen, Germany. European Journal of Medical Research [1998, 3(11):511-514

4.- Gerhardt H1, Seifert F, Buvari P, Vogelsang H, Repges R.Therapy of active Crohn disease with Boswellia serrata extract H 15. Gastroenterol. 2001 Jan; 39(1):11-7

5.- Singh S1, Khajuria A, Taneja SC, Khajuria RK, Singh J, Johri RK, Qazi GN. The gastric ulcer protective effect of boswellic acids, a leukotriene inhibitor from Boswellia serrata, in rats. Phytomedicine. 2008 Jun; 15(6-7):408-15

6.- Abdel-Tawab M, Werz O, Schubert-Zsilavecz M. Boswellia serrata: an overall assessment of in vitro, preclinical, pharmacokinetic and clinical data. Clin Pharmacokinet. 2011 Jun; 50(6):349-69.

7.- Kirste S, Treier M, Wehrle SJ, Becker G, Abdel-Tawab M, Gerbeth K, Hug MJ, Lubrich B, Grosu AL, Momm F. Boswellia serrata acts on cerebral edema in patients irradiated for brain tumors: a prospective, randomized, placebo-controlled, double-blind pilot trial. Cancer. 2011 Aug 15; 117(16):3788-95